Your browser doesn't support javascript.
loading
Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery.
Marron, Thomas U; Galsky, Matthew D; Taouli, Bachir; Fiel, Maria Isabel; Ward, Stephen; Kim, Edward; Yankelevitz, David; Doroshow, Deborah; Guttman-Yassky, Emma; Ungar, Benjamin; Mehandru, Saurabh; Golas, Benjamin J; Labow, Daniel; Sfakianos, John; Nair, Sujit S; Chakravarty, Dimple; Buckstein, Michael; Song, Xiaoyu; Kenigsberg, Effi; Gnjatic, Sacha; Brown, Brian D; Sparano, Joseph; Tewari, Ashutosh; Schwartz, Myron; Bhardwaj, Nina; Merad, Miriam.
Afiliação
  • Marron TU; The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
  • Galsky MD; Immunotherapy and Novel TargEt Research Across Clinical Teams (INTERACT), Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
  • Taouli B; Early Phase Trials Unit, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
  • Fiel MI; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
  • Ward S; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
  • Kim E; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
  • Yankelevitz D; Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
  • Doroshow D; Center of Excellence for Liver and Bile Duct Cancer, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
  • Guttman-Yassky E; Liver Cancer Program, Division of Liver Diseases and RM Transplant Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Thomas.marron@mssm.edu.
  • Ungar B; The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Mehandru S; Early Phase Trials Unit, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Golas BJ; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Labow D; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Sfakianos J; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Nair SS; The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Chakravarty D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Buckstein M; Center of Excellence for Liver and Bile Duct Cancer, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Song X; Liver Cancer Program, Division of Liver Diseases and RM Transplant Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Kenigsberg E; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gnjatic S; BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Brown BD; The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Sparano J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Tewari A; Center of Excellence for Liver and Bile Duct Cancer, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Schwartz M; Liver Cancer Program, Division of Liver Diseases and RM Transplant Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bhardwaj N; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Merad M; The neoAdjuvant Research Group to Evaluate Therapeutics (TARGET), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nat Med ; 28(4): 626-629, 2022 04.
Article em En | MEDLINE | ID: mdl-35347282
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article